With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Epigenetic therapies to concurrently target DIPG tumor cells and harness the immune system||The Regents of the University of Michigan / Sriram Venneti, MD/PhD||R Accelerated Award Grants||2022||Michigan|
|Phase I trial of multilamellar mRNA lipid particles for recurrent pediatric high grade glioma||University of Florida / Elias Sayour, MD/PhD||R Accelerated Award Grants||2022||Florida|
|GENOME ORIGAMI: Refolding Aberrant Chromosome 3D Structure for Treating NUT Carcinoma||Baylor College of Medicine / Kyle Eagen, PhD||R Accelerated Award Grants||2022||Texas|
|Understanding and inhibiting mechanisms of metastatic spread in osteosarcoma||University of California San Francisco / Alejandro Sweet-Cordero, MD||Crazy 8 Awards||2022||California|
|Targeting the biological underpinnings of pulmonary metastasis in osteosarcoma||Dana-Farber Cancer Institute / Rani George, MD/PhD||Crazy 8 Awards||2022||Massachusetts|
|Using Chemical Genetics to Define the Precise Role of RUNX1 in Transcription and Beyond||Albert Einstein College of Medicine / Kristy Stengel||RUNX1 Early Career Investigator Grants||2022||New York|
|Delivering on the Promise of Germline Genetic Testing for RUNX1 Variants||University of Washington, Seattle / Abbye McEwen, MD, PhD||RUNX1 Early Career Investigator Grants||2022||Washington|
|Enhancing TKI Therapy in Ph-Like Leukemia||The Regents of the University of California, Irvine / David Fruman, PhD||Reach Grants||2022||California|
|Mechanistic and Therapeutic Development of ATM as a Tumor Cell Selective Target for Radiosensitization in H3K27M DMG||The Regents of the University of Michigan / Meredith Morgan, PhD & Daniel Wahl, MD/PhD||Reach Grants||2022||Michigan|
|Novel Therapy for Pediatric Leukemia Patients with NUP98 Translocations||The Regents of the University of Michigan / Jolanta Grembecka, PhD||Reach Grants||2022||Michigan|